Paeonol Promotes Reendothelialization After Vascular Injury Through Activation of c-Myc/VEGFR2 Signaling Pathway
Drug Design, Development and Therapy · 2023
DOI: 10.2147/dddt.s403134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Yang Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China. Hauptthemen laut MEDLINE: Vascular System Injuries, Carotid Artery Injuries. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
- School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
Zitieren
APA
Wang, Y., Wang, Z., Wu, X., Zhu, S., Guo, Q., Jin, Z., Chen, Z., Zhang, D., Hu, W., Xu, H., Shi, L., Yang, L., & Wang, Y. (2023). Paeonol Promotes Reendothelialization After Vascular Injury Through Activation of c-Myc/VEGFR2 Signaling Pathway. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s403134
Vancouver
Wang Y, Wang Z, Wu X, Zhu S, Guo Q, Jin Z, et al. Paeonol Promotes Reendothelialization After Vascular Injury Through Activation of c-Myc/VEGFR2 Signaling Pathway. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s403134
BibTeX
@article{Wang2023,
author = {Wang, Yang and Wang, Zheng and Wu, Xiao and Zhu, Song and Guo, Qiru and Jin, Zhong and Chen, Zixian and Zhang, Delai and Hu, Wangming and Xu, Huan and Shi, Liangqin and Yang, Lan and Wang, Yong},
title = {Paeonol Promotes Reendothelialization After Vascular Injury Through Activation of c-Myc/VEGFR2 Signaling Pathway},
journal = {Drug Design, Development and Therapy},
year = {2023},
doi = {10.2147/dddt.s403134}
}
EUVIMED